Methods of improving the therapeutic efficacy and utility of antibody fragments

Details for Australian Patent Application No. 2009311233 (hide)

Owner University of Guelph

Inventors Hall, Christopher J.; McLean, Michael D.; Xie, Xuemei; Weisser, Nina; Almquist, Kurt C.

Agent Davies Collison Cave

Pub. Number AU-A-2009311233

PCT Pub. Number WO2010/051635

Priority 61/111,915 06.11.08 US

Filing date 6 November 2009

Wipo publication date 14 May 2010

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/051635 Priority application(s): WO2010/051635

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009311234-Combination of an oxidant and a photoactivator for the healing of wounds

2009311232-Human progenitor T-cells